Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Symptom |liver fibrosis
Sentences 187
PubMedID- 26486937 Objectives: to prospectively investigate the usefulness of acoustic structure quantification (asq) for noninvasive assessment of liver fibrosis in patients with chronic hepatitis b (chb).
PubMedID- 21150136 The objective of this study was to examine the relationship between urinary lcn2 levels and mmp-9 activity with respect to the stage of liver fibrosis in patients with chronic hepatitis c (chc), and to assess the utility of urine lcn2 as a non-invasive marker of hepatic fibrosis.
PubMedID- 25961575 These two methods are now recommended for first-line evaluation of liver fibrosis in patients with chronic hepatitis c 6.
PubMedID- 22481681 Assessment of portal venous index as a non-invasive method for diagnosing liver fibrosis in patients with chronic hepatitis c.
PubMedID- 19922441 A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis c recurrence after liver transplantation.
PubMedID- 23080492 Influence of b cells in liver fibrosis associated with hepatitis b virus harboring basal core promoter mutations.
PubMedID- 23049764 Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis b: a meta-analysis.
PubMedID- 20796157 Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis b.
PubMedID- 21387753 Age/plt, apri and forns seems to be helpful in prediction of early stage of liver fibrosis in patients with chronic hepatitis c.
PubMedID- 22453133 The effects of long-term cart on liver fibrosis in patients with or without hepatitis co-infection and the involvement of the metabolic syndrome continue to be controversially discussed.
PubMedID- 23269016 Purpose: we evaluated the use of magnetic resonance (mr) elastography (mre) for staging liver fibrosis in patients with chronic hepatitis c and compared the ability of mre and serum fibrosis markers for discriminating each stage of fibrosis.
PubMedID- 24926259 Chronic hepatitis c patients with advanced liver fibrosis are at risk for hepatocellular carcinoma (hcc).
PubMedID- 23358121 Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis b virus infection.
PubMedID- 26427080 Efficacy and safety of fuzhenghuayu capsule for treating liver fibrosis in patients with chronic hepatitis b: a meta-analysis.
PubMedID- 23325286 Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis b.
PubMedID- 24103280 Conclusions: the elf test is a promising non-invasive method for assessing liver fibrosis in patients with chronic hepatitis c.
PubMedID- 24282481 In this study, we investigated associations between serum cp levels and inflammation grade and liver fibrosis stages in patients with chronic hepatitis b-virus related liver disease.
PubMedID- 24957365 In turn, insulin resistance in chronic hepatitis c is associated with progression of liver fibrosis, resistance to antiviral therapy and development of hepatocellular carcinoma.
PubMedID- 20723207 Background: hyaluronic acid (ha) serum levels correlate with the histological stages of liver fibrosis in hepatitis c virus (hcv) monoinfected patients, and ha alone has shown very good diagnostic accuracy as a non-invasive assessment of fibrosis and cirrhosis.
PubMedID- 22677713 Early-onset liver fibrosis due to primary hepatitis c virus infection is higher over time in hiv-infected men.
PubMedID- 21468012 Objectives: precise evaluation of the level of liver fibrosis is recommended in patients with chronic hepatitis c (chc).
PubMedID- 21898504 Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis c: new algorithms are more precise and entirely noninvasive.
PubMedID- 26573189 Diagnostic value of fibrotest for liver fibrosis in patients with chronic hepatitis b.
PubMedID- 24721240 Objective: to prospectively evaluate the efficacy of a traditional chinese medicine (tcm)-based therapy for treating liver fibrosis in patients with chronic hepatitis b (chb), and to investigate the patients' perception of the treatment's effects on quality of life (qol).
PubMedID- 23085648 Background & aims: the progression of liver fibrosis in patients with chronic hepatitis c (chc) is important to decide on the treatment of the virus.
PubMedID- 23626613 The association of non-o blood group and severity of liver fibrosis in patients with chronic hepatitis c infection.
PubMedID- 26260921 liver fibrosis develops in patients with chronic hepatitis b because of repeated necroinflammation, followed by hepatocyte regeneration and the accumulation of extracellular matrix (ecm) proteins, such as collagen56.
PubMedID- 22129438 These histological classifications permitted the development of several non-invasive tests for the diagnosis of liver fibrosis, mainly due to hepatitis c virus (hcv).
PubMedID- 22761838 Discovery of novel biomarker candidates for liver fibrosis in hepatitis c patients: a preliminary study.
PubMedID- 21296375 Collectively, these observations provide insight into the mechanism of tgf-beta1 activation, which likely manifest in liver fibrosis associated with hepatitis c infection.
PubMedID- 22110596 We evaluated whether adiponectin level was associated with the prevalence and histological grade of hepatocellular carcinoma (hcc), and liver fibrosis in patients with hepatitis c virus (hcv) infection.
PubMedID- 25545640 Objective: liver fibrosis has been associated with hepatitis c virus (hcv) genotype and genetic variation near the interleukin 28b (il28b) gene, but the relative contribution is unknown.
PubMedID- 21735832 Assessment of liver fibrosis in patients with chronic hepatitis c (chc) is essential for determination of prognosis, monitoring of the disease and guiding therapeutic decisions.
PubMedID- 21140473 Accelerated liver fibrosis in hepatitis b virus transgenic mice: involvement of natural killer t cells.
PubMedID- 25167956 Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis b.
PubMedID- 22173159 We aimed at assessing the prognostic ability of (13)c(2)-aminopyrine breath test ((13)c-abt) in the prediction of liver fibrosis progression in patients with hcv chronic hepatitis who prospectively entered a long-term follow-up.
PubMedID- 21651482 Similar results were also observed in human patients with liver fibrosis due to autoimmune hepatitis and biliary etiology.
PubMedID- 24223606 The frequency of th17 cells in the diseased liver correlates with liver fibrosis in patients with viral hepatitis , aih , and alcoholic liver disease .
PubMedID- 22412904 This finding represents the first such liver disease association since intronic k8/k18 variants did not associate with liver fibrosis development in patients with chronic hepatitis c infection .
PubMedID- 23256120 Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis c.
PubMedID- 22772739 We aimed to determine the optimal time for restoring the reliability of lsm for assessing liver fibrosis in patients with chronic hepatitis b experiencing acute exacerbation.
PubMedID- 25874509 Background/aim: to date, liver biopsy has been the gold standard used for the assessment of liver fibrosis in patients with chronic hepatitis c.
PubMedID- 24748897 However, these tests or methods that may indicate liver fibrosis in patients with chronic hepatitis have been studied in patients with chronic hepatitis c and hepatic steatosis (7, 9, 14-16).
PubMedID- 22536445 Accurate assessment of the severity of liver fibrosis in patients with chronic hepatitis b (chb) is necessary not only for predicting the long-term clinical course, but also for determining whether and when to begin antiviral therapy.
PubMedID- 20441599 Our previous studies showed that sal b had obvious therapeutic effects against liver fibrosis in patients with chronic hepatitis b and animal models induced by dimethylnitrosamine , and its mechanism was closely associated with the inhibition of hepatic stellate cell activation through the regulation of tgf-β/smads signaling .
PubMedID- 26357427 Therefore, it is important to diagnoseliver fibrosis in patients with chronic viral hepatitis in order to predict, cure, andprevent the progress of disease.
PubMedID- 23791352 Tdi and tsi with quantitative measurements using tissue doppler analysis software (tdiq, ge medical systems, horten, norway) provided reliable information for evaluating non-invasive liver fibrosis in patients with chronic hepatitis b.
PubMedID- 23298655 Serum markers of liver fibrosis in patients with chronic hepatitis c infection.
PubMedID- 24521427 Transient elastography should not be used to assess liver fibrosis during acute flares of viral hepatitis because readings are falsely elevated.
PubMedID- 24023984 Serum complement c4a and its relation to liver fibrosis in children with chronic hepatitis c.

Page: 1 2 3 4